Bivalirudin (Angiox) for acute coronary syndromes: SMC review
The Scottish Medicines Consortium issued on 7th December, 2008 an advice on bivalirudin (Angiox): Bivalirudin (Angiox) is accepted for restricted use within NHS Scotland for the treatment of adult patients with acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) planned for urgent or early intervention. It is restricted to use in patients who would […]